208 related articles for article (PubMed ID: 15207337)
1. Endothelin and the tumorigenic component of bone cancer pain.
Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.
Sabino MA; Ghilardi JR; Jongen JL; Keyser CP; Luger NM; Mach DB; Peters CM; Rogers SD; Schwei MJ; de Felipe C; Mantyh PW
Cancer Res; 2002 Dec; 62(24):7343-9. PubMed ID: 12499278
[TBL] [Abstract][Full Text] [Related]
3. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin diminishes advanced bone cancer pain.
Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
[TBL] [Abstract][Full Text] [Related]
5. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.
Sevcik MA; Luger NM; Mach DB; Sabino MA; Peters CM; Ghilardi JR; Schwei MJ; Röhrich H; De Felipe C; Kuskowski MA; Mantyh PW
Pain; 2004 Sep; 111(1-2):169-80. PubMed ID: 15327821
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.
Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A
Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319
[TBL] [Abstract][Full Text] [Related]
7. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Furuse S; Kawamata T; Yamamoto J; Niiyama Y; Omote K; Watanabe M; Namiki A
Anesthesiology; 2009 Jul; 111(1):173-86. PubMed ID: 19512863
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes.
Berti-Mattera LN; Gariepy CE; Burke RM; Hall AK
Exp Neurol; 2006 Oct; 201(2):399-406. PubMed ID: 16806184
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of osteoblastic metastases: role of endothelin-1.
Mohammad KS; Guise TA
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S67-74. PubMed ID: 14600594
[TBL] [Abstract][Full Text] [Related]
10. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
[TBL] [Abstract][Full Text] [Related]
11. A mechanism-based understanding of bone cancer pain.
Mantyh PW
Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
[TBL] [Abstract][Full Text] [Related]
12. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.
Peters CM; Ghilardi JR; Keyser CP; Kubota K; Lindsay TH; Luger NM; Mach DB; Schwei MJ; Sevcik MA; Mantyh PW
Exp Neurol; 2005 May; 193(1):85-100. PubMed ID: 15817267
[TBL] [Abstract][Full Text] [Related]
14. Bone cancer pain.
Clohisy DR; Mantyh PW
Cancer; 2003 Feb; 97(3 Suppl):866-73. PubMed ID: 12548588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.
Wülfing P; Götte M; Sonntag B; Kersting C; Schmidt H; Wülfing C; Buerger H; Greb R; Böcker W; Kiesel L
Int J Oncol; 2005 Apr; 26(4):951-60. PubMed ID: 15753989
[TBL] [Abstract][Full Text] [Related]
16. Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion.
Park HC; Seong J; An JH; Kim J; Kim UJ; Lee BW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1523-34. PubMed ID: 15817359
[TBL] [Abstract][Full Text] [Related]
17. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury.
Zhang J; De Koninck Y
J Neurochem; 2006 May; 97(3):772-83. PubMed ID: 16524371
[TBL] [Abstract][Full Text] [Related]
18. Nociceptive sensitization by endothelin-1.
Hans G; Schmidt BL; Strichartz G
Brain Res Rev; 2009 Apr; 60(1):36-42. PubMed ID: 19150466
[TBL] [Abstract][Full Text] [Related]
19. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
Carducci MA; Jimeno A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6296s-6300s. PubMed ID: 17062717
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options.
Hans G; Deseure K; Adriaensen H
Neuropeptides; 2008 Apr; 42(2):119-32. PubMed ID: 18194815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
